Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Inhibit Triple-Negative Breast Cancer Cell Stemness and Metastasis via an ALKBH5-Dependent Mechanism
Open Access
Abstract
Background: Abnormal N6-methyladenosine (m6A) modification caused by m6A regulators is a common characteristic in various tumors. However, little is known about the role of m6A regulator AlkB homolog 5 (ALKBH5) in triple-negative breast cancer (TNBC). In this study, we analyzed the influence of ALKBH5 on the stemness of TNBC and the molecular mechanism using bioinformatics analysis and in vivo animal experiments. Methods: RNA expression data and single-cell RNA sequencing (scRNA-seq) data were downloaded from the TCGA and GEO databases. Following intersection analysis, key genes involved in the TNBC cell stemness were determined, which was followed by functional enrichment analysis, PPI and survival analysis. Exosomes were extracted from bone marrow mesenchymal stem cells (BMSC-Exos) where ALKBH5 inhibition assay was conducted to verify their function in the biological characteristics of TNBC cells. Results: Bioinformatics analysis revealed 45 key genes of ALKBH5 regulating TNBC cell stemness. In addition, UBE2C was predicted as a key downstream gene and p53 was predicted as a downstream signaling of ALKBH5. In vivo data confirmed that ALKBH5 upregulated UBE2C expression by regulating the m6A modification of UBE2C and reduced p53 expression, thus promoting the stemness, growth and metastasis of TNBC cells. BMSC-Exos suppressed the tumor stemness, growth and metastasis of TNBC cells and ALKBH5 shRNA-loaded BMSC-Exos showed a more significant suppressive role. Conclusion: Taken together, our findings indicated that ALKBH5 shRNA-loaded BMSC-Exos reduced TNBC cell stemness, growth and metastasis and define a promising strategy to treat TNBC.Keywords
Funding Information
- The Fund of Jiangsu Cancer Hospital (202013, 2020)
- Special Project for the Development of traditional Chinese Medicine Science and Technology in Jiangsu Province (202013, 2020)
This publication has 38 references indexed in Scilit:
- Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progressionOncogenesis, 2018
- Emerging Non-Canonical Functions and Regulation by p53: p53 and StemnessInternational Journal of Molecular Sciences, 2016
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNAProceedings of the National Academy of Sciences, 2016
- Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle ArrestStem Cell Reports, 2015
- MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancerOncology Reports, 2015
- Extracellular vesicles: Exosomes, microvesicles, and friendsJournal of Cell Biology, 2013
- Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyAnnals of Oncology, 2011
- p53 is balancing development, differentiation and de-differentiation to assure cancer preventionCarcinogenesis, 2010
- Validation of UBE2C protein as a prognostic marker in node-positive breast cancerBritish Journal of Cancer, 2009
- p53 and its isoforms in cancerBritish Journal of Cancer, 2007